SCHEMBL6701409

SCHEMBL6701409

COC(=O)C(Cc1ccc(OCC(=O)OC(C)(C)C)cc1)OCc1ccc(F)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.45
MEN1 O00255 2/20 0.45
GPR34 Q9UPC5 2/20 0.43
GAA P10253 1/20 0.41
PTPN1 P18031 2/20 0.41
PPARA Q07869 1/20 0.40
MAOB P27338 1/20 0.40
PSEN1 P49768 1/20 0.39
PSEN2 P49810 1/20 0.39
APH1B Q8WW43 1/20 0.39
NCSTN Q92542 1/20 0.39
APH1A Q96BI3 1/20 0.39
PSENEN Q9NZ42 1/20 0.39
FFAR1 O14842 1/20 0.39
NPC1 O15118 1/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
LTA4H P09960 1/20 0.39
LMNA P02545 2/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14854834 0.91 PLA2G4B (0.44) KMT2AMEN1GAAPTPN1PPARA
SCHEMBL14855324 0.89 PTGS2 (0.44) GPR34PTPN1PPARAMAOBNPC1
SCHEMBL6704700 0.85 GPR34 (0.49) KMT2AMEN1GPR34GAAPPARA
SCHEMBL5024744 0.84 PTPN1 (0.47) KMT2AMEN1PTPN1PPARAPSEN1
SCHEMBL5024741 0.84 PTPN1 (0.47) KMT2AMEN1PTPN1PPARAPSEN1
SCHEMBL14855546 0.83 MAOB (0.47) KMT2AMEN1GPR34MAOBFFAR1
SCHEMBL1676964 0.79 PSEN1 (0.51) KMT2AMEN1GAAPTPN1MAOB
SCHEMBL6698814 0.78 PTPN1 (0.47) KMT2AMEN1PTPN1PPARAPSEN1
SCHEMBL8763598 0.77 PTPN1 (0.47) KMT2AMEN1PTPN1PPARAPSEN1
SCHEMBL7298611 0.77 PTPN1 (0.47) KMT2AMEN1PTPN1PPARAPSEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040002512-A1 Alpha-substituted carboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2004-01-01 US disclosed
US-6596751-B2 An insulin resistance improving agent, hypoglycemic agent, immunoregulatory agent, aldose reductase inhibitor, 5-lipoxygenase inhibitor, peroxidized lipid production suppressor, PPAR. activator, leukotriene antagonist, adipose SANKYO COMPANY LIMITED (JP) 2003-07-22 US disclosed
US-20030069294-A1 Alpha-substituted carboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-04-10 US disclosed
EP-1167357-A1 ALPHA-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES Sankyo Company, Limited (JP) 2002-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002512-A1 Alpha-substituted carboxylic acid derivatives SLC5A1, SLC2A1, GPR119 KMT2A 1979/4885MEN1 3577/4885GPR34 859/4885
US-20030069294-A1 Alpha-substituted carboxylic acid derivatives SLC5A1, SLC2A1, GPR119 KMT2A 1979/4885MEN1 3577/4885GPR34 859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.